Research Output

Filter
Letter
2020

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

Hampel, P. J., Call, T. G., Ding, W., Muchtar, E., Kenderian, S. S., Wang, Y., Leis, J. F., Witzig, T. E., Koehler, A. B., Fonder, A. L., Schwager, S. M., Rabe, K. G., Van Dyke, D. L., Braggio, E., Slager, S. L., Kay, N. E. & Parikh, S. A., Mar 1 2020, In : American journal of hematology. 95, 3, p. E57-E60

Research output: Contribution to journalLetter

Open Access

Pretransplant body mass index on outcomes of allogeneic hematopoietic stem cell transplantation

Tai, J., Buras, M., Leis, J., Noel, P., Palmer, J., Slack, J. & Sproat, L., Jun 1 2020, In : Bone Marrow Transplantation. 55, 6, p. 1175-1177 3 p.

Research output: Contribution to journalLetter

The Role of Maintenance Therapy in Metastatic Colorectal Cancer - Reply

Sonbol, M. B., Murad, M. H. & Bekaii-Saab, T., Jun 2020, In : JAMA Oncology. 6, 6, p. 937-938 2 p.

Research output: Contribution to journalLetter

Venetoclax for the treatment of translocation (11;14) AL amyloidosis

Sidiqi, M. H., Al Saleh, A. S., Leung, N., Jevremovic, D., Aljama, M. A., Gonsalves, W. I., Buadi, F. K., Kourelis, T. V., Warsame, R., Muchtar, E., Hobbs, M. A., Lacy, M. Q., Dingli, D., Go, R. S., Hayman, S. R., Rajkumar, S. V., Dispenzieri, A., Gertz, M. A., Kumar, S. K., Fonseca, R. & 1 others, Kapoor, P., May 1 2020, In : Blood cancer journal. 10, 5, 55.

Research output: Contribution to journalLetter

Open Access
2019

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

Mascarenhas, J., Kosiorek, H., Prchal, J., Yacoub, A., Berenzon, D., Baer, M. R., Ritchie, E., Silver, R. T., Kessler, C., Winton, E., Finazzi, M. C., Rambaldi, A., Vannucchi, A. M., Leibowitz, D., Rondelli, D., Arcasoy, M. O., Catchatourian, R., Vadakara, J., Rosti, V., Hexner, E. & 12 others, Kremyanskaya, M., Sandy, L., Tripodi, J., Najfeld, V., Farnoud, N., Salama, M. E., Weinberg, R. S., Rampal, R., Goldberg, J. D., Mesa, R., Dueck, A. C. & Hoffman, R., Dec 1 2019, In : Leukemia. 33, 12, p. 2974-2978 5 p.

Research output: Contribution to journalLetter

2 Scopus citations

Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials

Atkinson, T. M., Dueck, A. C., Satele, D. V., Thanarajasingam, G., Lafky, J. M., Sloan, J. A. & Basch, E., Jan 1 2019, (Accepted/In press) In : JAMA Oncology.

Research output: Contribution to journalLetter

1 Scopus citations

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

Vendramini, E., Bomben, R., Pozzo, F., Benedetti, D., Bittolo, T., Rossi, F. M., Dal Bo, M., Rabe, K. G., Pozzato, G., Zaja, F., Chiarenza, A., Di Raimondo, F., Braggio, E. D., Parikh, S. A., Kay, N. E., Shanafelt, T. D., Del Poeta, G., Gattei, V. & Zucchetto, A., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalLetter

Open Access
2 Scopus citations

MYC dysregulation in the progression of multiple myeloma

MMRF CoMMpass Network, Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

4 Scopus citations

Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance)

Deshields, T. L., Dueck, A. C., Rogers, K., Brown, J. R., Shanafelt, T., Mintzer, D. & Byrd, J. C., Aug 24 2019, In : Leukemia and Lymphoma. 60, 10, p. 2580-2583 4 p.

Research output: Contribution to journalLetter

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis

Mascarenhas, J., Baer, M. R., Kessler, C., Hexner, E., Tremblay, D., Price, L., Sandy, L., Weinberg, R., Pahl, H., Silverman, L. R., Goldberg, J. D., Kosiorek, H., Dueck, A. C. & Hoffman, R., Apr 16 2019, In : Leukemia and Lymphoma. 60, 5, p. 1343-1345 3 p.

Research output: Contribution to journalLetter

5 Scopus citations

Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer

Denis, F., Basch, E., Septans, A. L., Bennouna, J., Urban, T., Dueck, A. C. & Letellier, C., Jan 22 2019, In : JAMA - Journal of the American Medical Association. 321, 3, p. 306-307 2 p.

Research output: Contribution to journalLetter

31 Scopus citations
2018

Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing

Ruiz-Heredia, Y., Sánchez-Vega, B., Onecha, E., Barrio, S., Alonso, R., Martínez-Ávila, J. C., Cuenca, I., Agirre, X., Braggio, E. D., Hernández, M. T., Martínez, R., Rosiñol, L., Gutierrez, N., Martin-Ramos, M., Ocio, E. M., Echeveste, M. A., de Oteyza, J. P., Oriol, A., Bargay, J., Gironella, M. & 9 others, Ayala, R., Bladé, J., Mateos, M. V., Kortum, K. M., Stewart, A. K., García-Sanz, R., Miguel, J. S., Lahuerta, J. J. & Martinez-Lopez, J., Nov 1 2018, In : Haematologica. 103, 11, p. e544-e548

Research output: Contribution to journalLetter

5 Scopus citations

Nivolumab-associated bone marrow necrosis

Hilal, T., Bansal, P., Kelemen, K. & Slack, J. L., Feb 1 2018, In : Annals of Oncology. 29, 2, p. 513-514 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis

Parikh, S. A., Chaffee, K. G., Larson, M. C., Hampel, P. J., Call, T. G., Ding, W. D., Kenderian, S., Leis, J. F., Chanan Khan, A. A., Conte, M. J., Bowen, D., Schwager, S. M., Slager, S. L., Hanson, C. A., Kay, N. E. & Shanafelt, T. D., Jun 3 2018, In : Haematologica. 103, 6, p. e237-e240

Research output: Contribution to journalLetter

5 Scopus citations
2017

Authors' reply to comment What should be the endpoints of a symptomatic drug and its control?

Mesa, R. & Harrison, C., Nov 1 2017, In : The Lancet Haematology. 4, 11, p. e508-e509

Research output: Contribution to journalLetter

Authors' reply to letter to editor: Confusion solved; sort of

Abdel-Misih, S. & Bekaii-Saab, T., Aug 1 2017, In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 8, p. 975-976 2 p.

Research output: Contribution to journalLetter

Correlation between markers of bone metabolism and Vitamin D levels in patients with monoclonal gammopathy of undetermined significance (MGUS)

Lipe, B., Kambhampati, S., Van Veldhuizen, P., Yacoub, A., Aljitawi, O. & Mikhael, J. R., Dec 1 2017, In : Blood Cancer Journal. 7, 12, 646.

Research output: Contribution to journalLetter

2 Scopus citations

Feasibility study of online yoga for symptom management in patients with myeloproliferative neoplasms

Huberty, J., Eckert, R., Gowin, K., Mitchell, J., Dueck, A., Ginos, B. F., Larkey, L. & Mesa, R., Sep 30 2017, In : Haematologica. 102, 10, p. e384-e388

Research output: Contribution to journalLetter

8 Scopus citations

Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment

Basch, E., Deal, A. M., Dueck, A., Scher, H. I., Kris, M. G., Hudis, C. & Schrag, D., Jul 11 2017, In : JAMA - Journal of the American Medical Association. 318, 2, p. 197-198 2 p.

Research output: Contribution to journalLetter

428 Scopus citations

Patient-reported symptom monitoring during chemotherapy - Reply

Basch, E., Deal, A. M. & Dueck, A., Nov 21 2017, In : JAMA - Journal of the American Medical Association. 318, 19, p. 1935-1936 2 p.

Research output: Contribution to journalLetter

2 Scopus citations
1 Scopus citations

PKM2 and other key regulators of Warburg effect positively correlate with CD147 (EMMPRIN) gene expression and predict survival in multiple myeloma

Panchabhai, S., Schlam, I., Sebastian, S. & Fonseca, R., Apr 1 2017, In : Leukemia. 31, 4, p. 991-994 4 p.

Research output: Contribution to journalLetter

10 Scopus citations

Response to Drs von Hoff and Renschler

Ahn, D. & Bekaii-Saab, T., Jun 1 2017, In : Therapeutic Advances in Medical Oncology. 9, 6, p. 445-446 2 p.

Research output: Contribution to journalLetter

Systolic dysfunction associated with carfilzomib use in patients with multiple myeloma

Jain, T., Narayanasamy, H., Mikhael, J. R., Reeder, C. B., Bergsagel, P. L., Mayo, A., Stewart, A. K., Mookadam, F. & Fonseca, R., Dec 1 2017, In : Blood Cancer Journal. 7, 12, 642.

Research output: Contribution to journalLetter

4 Scopus citations
2016

A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma

Han, M., Murugesan, A., Bahlis, N. J., Song, K., White, D., Chen, C., Seftel, M. D., Howsen-Jan, K., Reece, D., Stewart, A. K., Xie, Y., Hay, A. E., Shepherd, L., Djurfeldt, M., Zhu, L., Meyer, R. M., Chen, B. E. & Reiman, T., Aug 4 2016, In : Blood. 128, 5, p. 732-735 4 p.

Research output: Contribution to journalLetter

1 Scopus citations

A phase Ib study of the combination of the aurora kinase inhibitor alisertib (MLN8237) and bortezomib in relapsed multiple myeloma

Rosenthal, A., Kumar, S. K., Hofmeister, C., Laubach, J., Vij, R., Dueck, A., Gano, K. & Stewart, A. K., Jul 1 2016, In : British Journal of Haematology. 174, 2, p. 323-325 3 p.

Research output: Contribution to journalLetter

14 Scopus citations

Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosis

Gowin, K., Coakley, M., Kosiorek, H. & Mesa, R., Sep 30 2016, In : Haematologica. 101, 10, p. e405-e406

Research output: Contribution to journalLetter

13 Scopus citations

In reply

Scherber, R. M. & Mesa, R. A., Sep 13 2016, In : JAMA - Journal of the American Medical Association. 316, 10, p. 1115 1 p.

Research output: Contribution to journalLetter

Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma

Jain, T., Dueck, A., Kosiorek, H. E., Ginos, B. F., Mayo, A., Reeder, C. B., Chesi, M., Mikhael, J. R., Stewart, A. K., Bergsagel, P. L. & Fonseca, R., Dec 1 2016, In : American Journal of Hematology. 91, 12, p. E504-E505

Research output: Contribution to journalLetter

2 Scopus citations

Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline

Ramanathan, R. K., Korn, R. L., Chiorean, E. G., Liu, H. & Von Hoff, D. D., Aug 1 2016, In : Annals of Oncology. 27, 8, p. 1647-1648 2 p.

Research output: Contribution to journalLetter

Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma

Panchabhai, S., Kelemen, K., Ahmann, G., Sebastian, S., Mantei, J. & Fonseca, R., Apr 1 2016, In : Leukemia. 30, 4, p. 951-954 4 p.

Research output: Contribution to journalLetter

19 Scopus citations
2015

Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies

Bogenberger, J. M., Delman, D., Hansen, N., Valdez, R., Fauble, V., Mesa, R. A. & Tibes, R., Jan 1 2015, In : Leukemia and Lymphoma. 56, 1, p. 226-229 4 p.

Research output: Contribution to journalLetter

44 Scopus citations

The efficacy of ibrutinib in the treatment of Richter syndrome

Tsang, M., Shanafelt, T. D., Call, T. G., Ding, W. D., Chanan Khan, A. A., Leis, J. F., Nowakowski, G. S., Bowen, D., Conte, M., Schwager, S. M., Slager, S. L., Kay, N. E., Hanson, C. A. & Parikh, S. A., 2015, In : Blood. 125, 10, p. 1676-1678 3 p.

Research output: Contribution to journalLetter

38 Scopus citations
2014

Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis

Ding, W., Shanafelt, T. D., Lesnick, C. E., Erlichman, C., Leis, J. F., Secreto, C., Sassoon, T. R., Call, T. G., Bowen, D. A., Conte, M., Kumar, S. & Kay, N. E., Jan 1 2014, In : British journal of haematology. 164, 1, p. 146-150 5 p.

Research output: Contribution to journalLetter

13 Scopus citations

Long-term follow-up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia

Chen, C. I., Paul, H., Wang, T., Le, L. W., Dave, N., Kukreti, V., Nong Wei, E., Lau, A., Bergsagel, P. L. & Trudel, S., Jun 2014, In : British journal of haematology. 165, 5, p. 731-733 3 p.

Research output: Contribution to journalLetter

16 Scopus citations

Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma

Reeder, C. B., Reece, D. E., Kukreti, V., Mikhael, J. R., Chen, C., Trudel, S., Laumann, K., Vohra, H., Fonseca, R., Bergsagel, P. L., Leis, J. F., Tiedemann, R. & Stewart, A. K., Nov 1 2014, In : British journal of haematology. 167, 4, p. 563-565 3 p.

Research output: Contribution to journalLetter

31 Scopus citations

Predicting multiple myeloma disease activity by analyzing natural calcium isotopic composition

Gordon, G. W., Monge, J., Channon, M. B., Wu, Q., Skulan, J. L., Anbar, A. D. & Fonseca, R., Oct 1 2014, In : Leukemia. 28, 10, p. 2112-2115 4 p.

Research output: Contribution to journalLetter

19 Scopus citations

Ruxolitinib in clinical practice for therapy of myelofibrosis: Single USA center experience following Food and Drug Administration approval

Geyer, H., Cannon, K., Knight, E., Fauble, V., Camoriano, J., Emanuel, R., Tibes, R. & Mesa, R., Jan 1 2014, In : Leukemia and Lymphoma. 55, 1, p. 195-197 3 p.

Research output: Contribution to journalLetter

17 Scopus citations

Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012

Reilly, J. T., Mcmullin, M. F., Beer, P. A., Butt, N., Conneally, E., Duncombe, A. S., Green, A. R., Mikhaeel, G., Gilleece, M. H., Knapper, S., Mead, A. J., Mesa, R. A., Sekhar, M. & Harrison, C. N., Nov 1 2014, In : British journal of haematology. 167, 3, p. 418-420 3 p.

Research output: Contribution to journalLetter

31 Scopus citations
2013

Degree of focal immunoglobulin heavy chain locus deletion as a measure of B-cell tumor purity

Bergsagel, P. L. & Kuehl, W. M., Oct 1 2013, In : Leukemia. 27, 10, p. 2067-2111 45 p.

Research output: Contribution to journalLetter

3 Scopus citations

Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease

Egan, J. B., Kortuem, K. M., Kurdoglu, A., Izatt, T., Aldrich, J., Reiman, R., Phillips, L., Baker, A., Shi, C. X., Schmidt, J., Liang, W. S., Craig, D. W., Carpten, J. D. & Stewart, A. K., Jun 1 2013, In : British journal of haematology. 161, 5, p. 748-751 4 p.

Research output: Contribution to journalLetter

32 Scopus citations

Impact of prior acute GVHD on chronic GVHD outcomes: A chronic graft versus host disease consortium study

Arora, M., Pidala, J., Cutler, C. S., Chai, X., Kurland, B., Jacobsohn, D. A., Pavletic, S. Z., Palmer, J., Vogelsang, G., Jagasia, M., Schultz, K. & Lee, S. J., May 1 2013, In : Leukemia. 27, 5, p. 1196-1201 6 p.

Research output: Contribution to journalLetter

8 Scopus citations

In response

Weber, M. A., Fonseca, R. & Stossel, T. P., Mar 1 2013, In : Endocrine Practice. 19, 2, 1 p.

Research output: Contribution to journalLetter

In response

Weber, M. A., Black, H. R., Fonseca, R., Garber, J. R., Gonzalez-Campoy, M., Kimmelstiel, C., Markowitz, A. B., Nakayama, D., Stell, L. K. & Stossel, T. P., Mar 1 2013, In : Endocrine Practice. 19, 2, p. 380-381 2 p.

Research output: Contribution to journalLetter

Persistent human rhinovirus type C infection of the lower respiratory tract in a pediatric cord blood transplant recipient

Pathak, A. K., Adams, R. H., Shah, N. C. & Gustin, K. E., May 1 2013, In : Bone Marrow Transplantation. 48, 5, p. 747-748 2 p.

Research output: Contribution to journalLetter

8 Scopus citations
2012

Adaptive trials in the neoadjuvant setting: A model to safely tailor care while accelerating drug development

Yee, D., Haddad, T., Albain, K., Barker, A., Benz, C., Boughey, J., Buxton, M., Chien, A. J., DeMichele, A., Dilts, D., Elias, A., Haluska, P., Hogarth, M., Hu, A., Hytlon, N., Kaplan, H. G., Kelloff, G. G., Khan, Q., Lang, J., Leyland-Jones, B. & 18 others, Liu, M., Nanda, R., Northfelt, D., Olopade, O. I., Park, J., Parker, B., Parkinson, D., Pearson-White, S., Perlmutter, J., Pusztai, L., Symmans, F., Rugo, H., Tripathy, D., Wallace, A., Wholley, D., Van't Veer, L., Berry, D. A. & Esserman, L., Dec 20 2012, In : Journal of Clinical Oncology. 30, 36, p. 4584-4586 3 p.

Research output: Contribution to journalLetter

11 Scopus citations

Dr. Verstovsek and Colleagues reply

Verstovsek, S., Mesa, R. A. & Kantarjian, H. M., May 24 2012, In : New England Journal of Medicine. 366, 21, 1 p.

Research output: Contribution to journalLetter

1 Scopus citations

How physicians interpret research funding disclosures [3]

Fonseca, R., Dec 13 2012, In : New England Journal of Medicine. 367, 24, p. 2358-2360 3 p.

Research output: Contribution to journalLetter